Black Friday Sale - Ends Soon!
-35% Off Everything
ABT

Abbott Laboratories (ABT)

Last Price$118.8(0.2%)
Market Cap$196.8B
LTM Revenue
$41.2B
YoY Growth
+3.1%
3Y CAGR
-0.9%
5Y CAGR
+5.6%
Stock quality & Intrinsic value
5/10
2.9% undervalued

Abbott Laboratories Revenue

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
$19.7B
$22.3B
$22.5B
$25.9B
$29.5B
$30.8B
$35.2B
$38.9B
$39.9B
$21.8B
$20.2B
$20.4B
$20.9B
$27.4B
$30.6B
$31.9B
$34.6B
$43.1B
$43.7B
$40.1B
ABT
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for ABT and see if it's the right time to invest.
Dive in

Abbott Laboratories (ABT) Revenue comparison analysis

Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Abbott Laboratories's Revenue?

As of today, Abbott Laboratories's last 12-month Revenue is $41.2B, based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is Abbott Laboratories's Revenue growth rate?

Over the last year, Abbott Laboratories's Revenue growth was 3.1%. The average annual Revenue growth rates for Abbott Laboratories have been 3.3% over the past three years, 5.6% over the past five years.

3) Is Abbott Laboratories's Revenue growth rate Good?

Over the last year, Abbott Laboratories's Revenue growth was 3.1%, which is higher than industry growth of 0.1%. It indicates that Abbott Laboratories's Revenue growth is Good.

4) How does Abbott Laboratories's Revenue growth rate compare to its peers?

Over the last year, Abbott Laboratories's Revenue growth was 3.1%, which is higher than peer median growth of 2.3%. The list of peers includes MDT, SYK, PHG, BSX, EW, STE, ALGN, DXCM, PODD, SWAV etc.